The real issue, Usdin suggests, is the tension between whistleblowers who can play a critical role when there is genuine malfeasance and the possibility of junior scientists, motivated by ideology, money or both, trying to circumvent the legitimate responsibility of senior management to make final decisions.
FORBES: FDA SpyGate -- New Revelations Challenge The New York Times Investigation of Agency "Enemies List," Raise More Questions About the 'Government's Most Dysfunctional Agency'